I agree that this site is using cookies. You can find further informations here.
X
Mugerwa, Henry
91  results:
Search for persons X
?
1

Early trajectories of virological and immunological biomark..:

Jensen, Tomas O ; Murray, Thomas A ; Grandits, Greg A...
The Lancet Microbe.  5 (2024)  6 - p. e559-e569 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Rosuvastatin adjunctive therapy for rifampicin-susceptible ..:

Cross, Gail B ; Sari, Intan P ; Kityo, Cissy...
The Lancet Infectious Diseases.  23 (2023)  7 - p. 847-855 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Pharmacokinetics and Safety of Twice-daily Ritonavir-booste..:

Gausi, Kamunkhwala ; Mugerwa, Henry ; Siccardi, Marco...
Clinical Infectious Diseases.  78 (2023)  5 - p. 1246-1255 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Effect of Neutralizing Monoclonal Antibody Treatment on Ear..:

Jensen, Tomas O ; Grandits, Greg A ; Jain, Mamta K...
The Journal of Infectious Diseases.  229 (2023)  3 - p. 671-679 , 2023
Link: https://doi.org/10.1093/..
 
?
5

Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated..:

Rasmussen, Thomas A ; Ahuja, Sunil K ; Kuwanda, Locadiah...
Clinical Infectious Diseases.  75 (2022)  10 - p. 1781-1791 , 2022
Link: https://doi.org/10.1093/..
 
?
6

Efficacy and safety of dolutegravir or darunavir in combina..:

Paton, Nicholas I ; Musaazi, Joseph ; Kityo, Cissy...
The Lancet HIV.  9 (2022)  6 - p. e381-e393 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Efficacy of Cipargamin (KAE609) in a Randomized, Phase II D..:

Schmitt, Esther K ; Ndayisaba, Gilles ; Yeka, Adoke...
Clinical Infectious Diseases.  74 (2021)  10 - p. 1831-1839 , 2021
Link: https://doi.org/10.1093/..
 
?
8

Facilitated transition in HIV drug trial closure: A concept..:

Nalubega, Sylivia ; Cox, Karen ; Mugerwa, Henry..
PLOS ONE.  16 (2021)  4 - p. e0250698 , 2021
Link: https://doi.org/10.1371/..
 
?
9

Predictors of failure on second-line antiretroviral therapy..:

Musana, Hellen ; Ssensamba, Jude Thaddeus ; Nakafeero, Mary...
AIDS Research and Therapy.  18 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
10

Ethical and practical considerations in HIV drug trial clos..:

Nalubega, Sylivia ; Cox, Karen ; Mugerwa, Henry.
Research Ethics.  17 (2021)  4 - p. 423-434 , 2021
Link: https://doi.org/10.1177/..
 
?
11

Hepatic safety and tolerability of cipargamin (KAE609), in ..:

Ndayisaba, Gilles ; Yeka, Adoke ; Asante, Kwaku Poku...
Malaria Journal.  20 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
12

Correction: Towards access for all: 1st Working Group Repor..:

Adair, Jennifer E. ; Androski, Lindsay ; Bayigga, Lois...
Gene Therapy.  30 (2021)  3-4 - p. 405-405 , 2021
Link: https://doi.org/10.1038/..
 
?
13

Urine Lipoarabinomannan Testing in Adults With Advanced Hum..:

Matoga, Mitch M ; Bisson, Gregory P ; Gupta, Amita...
Clinical Infectious Diseases.  73 (2021)  4 - p. e870-e877 , 2021
Link: https://doi.org/10.1093/..
 
?
14

Factors associated with virological non-suppression among H..:

Nabukeera, Sarah ; Kagaayi, Joseph ; Makumbi, Fredrick Edward...
PLOS ONE.  16 (2021)  1 - p. e0246140 , 2021
Link: https://doi.org/10.1371/..
 
?
15

Towards access for all: 1st Working Group Report for the Gl..:

Adair, Jennifer E. ; Androski, Lindsay ; Bayigga, Lois...
Gene Therapy.  30 (2021)  3-4 - p. 216-221 , 2021
Link: https://doi.org/10.1038/..
 
1-15